Larvol Delta - Study-to-Evaluate-the-Efficacy-and-Safety-of-Camidanlumab-Tesirine-ADCT301-in-Patients-With-Relapsed-or-Refractory-Hodgkin-Lymphoma

camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics

http://clinicaltrials.gov/ct2/show/NCT04052997

Mar 31, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next